hydroxychloroquine and crizotinib

hydroxychloroquine has been researched along with crizotinib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Deng, D; Han, W; Huang, W; Jiang, L; Jing, Z; Li, H; Pan, H; Pan, Q; Shou, J; Wang, Z; Xie, J; Yao, J; You, L	1
Alves-Costa-Silva, C; Derosa, L; Ferrere, G; Kepp, O; Kroemer, G; Liu, P; Ly, P; Tian, AL; Wu, Q; Zhao, L; Zitvogel, L	1

Other Studies

2 other study(ies) available for hydroxychloroquine and crizotinib

Article	Year
Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines. Oncotarget, 2015, Nov-24, Volume: 6, Issue:37 Topics: Animals; Autophagy; Cell Line, Tumor; Cell Survival; Crizotinib; Drug Synergism; Eukaryotic Initiation Factor-2; Female; Humans; Hydroxychloroquine; Immunoblotting; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Microtubule-Associated Proteins; Phagosomes; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Pyridines; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays	2015
Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses. Oncoimmunology, 2020, 07-08, Volume: 9, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azithromycin; Cell Line, Tumor; Cisplatin; Clinical Trials, Phase II as Topic; COVID-19; COVID-19 Drug Treatment; Crizotinib; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Female; France; Humans; Hydroxychloroquine; Mice; Neoplasms; Oxaliplatin; Programmed Cell Death 1 Receptor; SARS-CoV-2	2020

Article

Year

Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines.

Oncotarget, 2015, Nov-24, Volume: 6, Issue:37

Topics: Animals; Autophagy; Cell Line, Tumor; Cell Survival; Crizotinib; Drug Synergism; Eukaryotic Initiation Factor-2; Female; Humans; Hydroxychloroquine; Immunoblotting; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Microtubule-Associated Proteins; Phagosomes; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Pyridines; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays

2015

Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses.

Oncoimmunology, 2020, 07-08, Volume: 9, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azithromycin; Cell Line, Tumor; Cisplatin; Clinical Trials, Phase II as Topic; COVID-19; COVID-19 Drug Treatment; Crizotinib; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Female; France; Humans; Hydroxychloroquine; Mice; Neoplasms; Oxaliplatin; Programmed Cell Death 1 Receptor; SARS-CoV-2

2020